Vivos (RDGL) Depreciation & Amortization (CF) (2010 - 2017)
Vivos (RDGL) reported Depreciation & Amortization (CF) of $733.0 for Q2 2017, down 0.54% on a YoY basis from $737.0 in Q2 2016, and down 0.95% sequentially from $740.0 in Q1 2017.
Vivos (RDGL) Depreciation & Amortization (CF) (2010 - 2017) Analysis & Trends
Vivos (RDGL) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $733.0 in Q2 2017.
- For the quarter ending Q2 2017, Depreciation & Amortization (CF) fell 0.54% year-over-year to $733.0; the trailing twelve-month figure through Mar 2018 stood at $733.0 (down 75.14% YoY), and the FY2025 full-year result was $374.0, changed N/A from the prior year.
- Depreciation & Amortization (CF) retreated to $733.0 in Q2 2017, from $740.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $112947.0 in Q1 2013 to a low of $733.0 in Q2 2017.
- A 5-year average of $11925.3 and a median of $1329.5 in 2015 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) plunged 98.64% in 2014 and grew 0.27% in 2017, its largest moves.
- Tracing RDGL's Depreciation & Amortization (CF) over 5 years: stood at $1540.0 in 2013, then changed by 0.0% to $1540.0 in 2014, then plunged by 52.08% to $738.0 in 2015, then fell by 0.54% to $734.0 in 2016, then declined by 0.14% to $733.0 in 2017.
- Business Quant data shows RDGL's Depreciation & Amortization (CF) at $733.0 in Q2 2017, $740.0 in Q1 2017, and $734.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | 40.90 Mn |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 78.00 Mn |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn | 67.10 Mn |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 310.25 Mn |
| 10 | Vivos | 26.71 Mn | 25.15 Mn | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 733.00 |
| Jun 30, 2017 | 733.00 |
| Mar 31, 2017 | 740.00 |
| Mar 31, 2017 | 740.00 |
| Dec 31, 2016 | 734.00 |
| Dec 31, 2016 | 734.00 |
| Sep 30, 2016 | 738.00 |
| Sep 30, 2016 | 738.00 |
| Jun 30, 2016 | 737.00 |
| Jun 30, 2016 | 737.00 |
| Mar 31, 2016 | 738.00 |
| Mar 31, 2016 | 738.00 |
| Dec 31, 2015 | 738.00 |
| Dec 31, 2015 | 738.00 |
| Sep 30, 2015 | 936.00 |
| Sep 30, 2015 | 936.00 |
| Jun 30, 2015 | 1,329.00 |
| Jun 30, 2015 | 1,329.00 |
| Mar 31, 2015 | 1,330.00 |
| Mar 31, 2015 | 1,330.00 |